
|Articles|January 1, 2004
A new advance in the treatment of photodamaged skin
The views and opinions expressed in this supplement are those of the faculty and do not necessarily reflect the views of Dermatology Times, Cosmetic Surgery Times, Advanstar Communications, Inc, or Allergan, Inc.Sponsored by an unrestricted education grant from Allergan
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
3
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














